Looking to gain a foothold in Ireland? MSD puts shuttered site up for sale

Image: iStock/Bigandt_Photography

Merck & Co. has put an Irish small molecule plant up for sale after ceasing production late last year.

The facility in Swords, County Dublin had been earmarked for closure back in 2013, but a spokesman for Merck Sharp & Dohme (MSD) – known as Merck & Co. in North America – confirmed to us “production ceased at the plant in December 2016 and MSD will exit in the Summer.”

As such, the 33 acre site is now available for sale through industrial agent, JLL.

According to JLL, “the property comprises 350,000 sq ft of flexible production, laboratory, utility, distribution and office space” and could be “of interest to existing global pharmaceutical users seeking to gain a foothold in the Irish Market.”

MSD’s decision to shutter the site was due to a network capacity and ongoing review of its manufacturing footprint following the merger with Schering-Plough in 2009, the company told this publication back in 2013.

The site – which manufactured formulated products in the areas of women’s health, anesthesia and psychiatry – is one of two Irish plants divested by MSD, the other an active pharmaceutical ingredient (API) in Rathdrum, County Wicklow put up or sale in 2013.

But despite this the Big Pharma firm has said it is committed to Ireland, investing in both capacities and staff at its biologics and vaccine manufacturing sites in Carlow, Cork and Tipperary.

Related News

Image: iStock/Harvepino

Merck & Co. €280m spend in latest commitment to Irish biomanufacturing

Image: iStock

Merck & Co. to hire 200 across its Irish biomanufacturing operations

Biopharma-Reporter investigates Ireland's biomanufacturing training centre

Inside NIBRT: Ireland’s 'flight simulator for biopharma manufacturing'

Merck & Co shuttering another irish facility

570 jobs to go at Merck & Co. Irish plant as part of network streamlining

Could biomanufacturing keep the flag flying in Ireland?

Shift to Biomanufacturing Offsetting Ireland's Small Molecule Woes

MSD facility in Brinney, Irelan (source Google)

Merck & Co. and Fujifilm team to share capabilities at new $60m microbial plant

MSD to close Irish API Plant

For Sale: Another Merck & Co API Plant - Cost, 280 Irish Jobs

Related Products

See more related products